Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Early Feasibility of BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants

NCT07849153 is registered in ClinicalTrials.gov with Biora Therapeutics, Inc. as lead sponsor.

NCT NCT07849153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07849153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Early Feasibility of BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy Participants
Lead sponsor
Biora Therapeutics, Inc.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
February 15, 2027
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects